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Abstract
Background: Emerging research suggests that mobile apps can be used to effectively treat common mental illnesses like
depression and anxiety. Despite promising efficacy results and ease of access to these interventions, adoption of mobile health
(mHealth; mobile device–delivered) interventions for mental illness has been limited. More insight into patients’ perspectives on
mHealth interventions is required to create effective implementation strategies and to adapt existing interventions to facilitate
higher rates of adoption.
Objective: The aim of this study was to examine, from the patient perspective, current use and factors that may impact the use
of mHealth interventions for mental illness.
Methods: This was a cross-sectional survey study of veterans who had attended an appointment at a single Veterans Health
Administration facility in early 2016 that was associated with one of the following mental health concerns: unipolar depression,
any anxiety disorder, or posttraumatic stress disorder. We used the Veteran Affairs Corporate Data Warehouse to create subsets
of eligible participants demographically stratified by gender (male or female) and minority status (white or nonwhite). From each
subset, 100 participants were selected at random and mailed a paper survey with items addressing the demographics, overall
health, mental health, technology ownership or use, interest in mobile app interventions for mental illness, reasons for use or
nonuse, and interest in specific features of mobile apps for mental illness.
Results: Of the 400 potential participants, 149 (37.3%, 149/400) completed and returned a survey. Most participants (79.9%,
119/149) reported that they owned a smart device and that they use apps in general (71.1%, 106/149). Most participants (73.1%,
87/149) reported interest in using an app for mental illness, but only 10.7% (16/149) had done so. Paired samples t tests indicated
that ratings of interest in using an app recommended by a clinician were significantly greater than general interest ratings and
even greater when the recommending clinician was a specialty mental health provider. The most frequent concerns related to
using an app for mental illness were lacking proof of efficacy (71.8%, 107/149), concerns about data privacy (59.1%, 88/149),
and not knowing where to find such an app (51.0%, 76/149). Participants expressed interest in a number of app features with
particularly high-interest ratings for context-sensitive apps (85.2%, 127/149), and apps focused on the following areas: increasing
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exercise (75.8%, 113/149), improving sleep (73.2%, 109/149), changing negative thinking (70.5%, 105/149), and increasing
involvement in activities (67.1%, 100/149).
Conclusions: Most respondents had access to devices to use mobile apps for mental illness, already used apps for other purposes,
and were interested in mobile apps for mental illness. Key factors that may improve adoption include provider endorsement,
greater publicity of efficacious apps, and clear messaging about efficacy and privacy of information. Finally, multifaceted apps
that address a range of concerns, from sleep to negative thought patterns, may be best received.
(JMIR Ment Health 2019;6(1):e11334)   doi:10.2196/11334
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Introduction
The majority of the US population owns smartphones (77% in
2016) [1], and the number of mobile apps for health has grown
exponentially over the past decade. A study by the IMS Institute
for Healthcare Informatics [2] found that the number of health
and wellness apps available to consumers has more than doubled
between 2013 and 2015 (from 43,000 to over 90,000). Although
the content and quality of these apps vary widely, the potential
public health impact of such tools is enormous. Research
suggests that mobile health (mHealth) interventions can have
a positive influence on a wide range of health conditions [3,4]
and, while not a substitute for in-person treatment, these tools
offer a treatment option that does not have as many access
barriers as in-office treatment (eg, no transportation is required)
and may allow for reduced cost of care (since marginal cost is
negligible).
In mental illness—where stigma and self-reliance beliefs are
additional barriers to treatment seeking and engagement
[5]—mobile health (mHealth) offers even greater potential.
Common mental health disorders such as depression and anxiety
impact nearly a third of the US population, and most of those
who need treatment do not receive it [6,7]. The sheer number
of people affected makes providing adequate treatment in
traditional clinical settings prohibitive in terms of availability
of trained providers. Studies indicate that mHealth interventions
can improve functioning and symptoms in those with depression
and/or anxiety [8-11] and also that technology offers some
advantages over in-person treatments. Specifically, mHealth
interventions offer 24/7 support because mobile devices are
often kept with users throughout the day. In addition, patients
may be more likely to report severe symptoms on technology
platforms than in person [12], and patients value the autonomy
and empowerment that can be offered by such platforms [13].
Unfortunately, adoption of mHealth interventions for common
mental illnesses such as depression and anxiety remains low.
To date, mHealth is neither a routine part of mental health care
offerings in the United States nor has any mHealth platform for
mental illness been widely adopted by consumers in the United
States. These patterns are particularly noteworthy in systems
such as the Veterans Health Administration (VHA), which has
invested substantially in building and evaluating several free
behavioral health apps specifically designed for mental health
concerns of veterans. Several theoretical models explaining
technology adoption and continued use have been put forth in
the literature [14-16]. Existing models have some conflicting
and some overlapping components and have been found to
explain as little as 17% and as much as 53% of the variance in
adoption [15]. Newer unified models may explain more of the
variance in adoption and use, but much of this literature has
traditionally focused largely on adoption of technology in the
workplace, a considerably different context than the treatment
of mental illness. This multifaceted theoretical canvas
underscores the complexity of understanding adoption and the
potential importance of studying specific types of technology
within the intended use population. At present, it is unclear what
are the best approaches for encouraging patient adoption of
mHealth interventions.
Research on patient adoption of technology in treatment of
mental illness suggests that interest outpaces adoption.
Specifically, studies of patients with depression, anxiety, and
posttraumatic stress disorder (PTSD) suggest that interest varies
widely based on the type of technology in question, but most
patients are interested in using some kinds of technology in
treatment [17,18]. With regard to mHealth specifically, Erbes
et al [19] found that over half of a sample of patients with PTSD
expressed interest in mHealth programs for PTSD, but less than
10% were currently using these platforms to help manage their
symptoms.
Given high interest and low adoption, there is a need to build a
stronger understanding of the factors that may affect adoption
at the system level. Research on other patient-facing
technologies suggests that how such technologies are integrated
into the health care system may impact patient adoption. For
example, findings from studies focused on adoption of one Web
portal indicate that provider endorsement can improve rates of
adoption [20]. It remains to be determined whether this is the
case for mHealth interventions.
There is also a need to build a stronger understanding of factors
that may affect adoption at the patient level. A large national
survey of health app use in the general population indicated that
lack of interest, cost, and concern about data privacy were key
barriers to adoption [21]. These findings have been reinforced
in other studies focused on mental health apps. Specifically, a
study focused on mHealth interventions for depression found
that cost, concerns about privacy, concerns over intervention
efficacy, and misfit of intervention features to needs (ie,
personalization) were key barriers to adoption of depression
apps [22]. Another study focused on health and mental health
apps found that efficacy and privacy are key barriers to adoption
as well as not knowing where to find an app or knowing which
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app to download [23]. However, these studies were conducted
using only partially clinical samples, that is, presence of
clinically significant symptoms (on self-report or via medical
record diagnosis) was either not an eligibility criterion or not
assessed.
Stronger understanding of patient perspectives on mHealth
interventions in relevant clinical samples is required to support
the development of targeted implementation strategies and
platform modifications that will ultimately promote adoption.
The aim of this study was to characterize mHealth interest,
concerns, and preferences in a sample of patients with an active
diagnosis of depression, anxiety, and/or PTSD. Specifically,
we sought to (1) identify patients’ degree of interest in mHealth
interventions for mental health, (2) identify whether provider
endorsement would impact degree of interest, (3) determine
reasons for nonuse of mHealth interventions for mental health,
and (4) identify what mHealth content or features are of most
interest to patients.
Methods
Recruitment
We used the Veterans Affairs (VA) Corporate Data Warehouse
(CDW) to identify individuals meeting eligibility criteria and
to extract contact and diagnostic information for those
individuals. Eligibility criteria were as follows: (1) US military
veteran enrolled in care at the VA Boston Healthcare System;
(2) receiving VA primary care, as indicated by having at least
one encounter in the local primary care clinic between January
1, 2016, and July 1, 2016; (3) aged 18 years or older; and (4)
attended a VA medical appointment between January 1, 2016,
and July 1, 2016, in which an anxiety disorder (including
obsessive-compulsive disorder), unipolar depressive disorder,
or PTSD was documented as a condition treated in the
appointment. Codes based on the 10th revision of the
International Statistical Classification of Diseases and Related
Health Problems (ICD-10) were used to determine visits
associated with unipolar depression (F32-F34) and anxiety and
PTSD (F40-F43). The decision to include patients with any or
all of these diagnoses in the sample was based on high
comorbidity rates between these diagnoses and the similarity
of pharmacological and psychotherapeutic treatments for these
disorders [24-29].
A total of 2840 veterans in the CDW met the above criteria.
Within this sample, we divided records into 4 strata (white men,
nonwhite men, white women, and nonwhite women) and
randomly sampled 100 records from each stratum to achieve a
gender- and minority-balanced set of potential participants.
These randomly selected 400 individuals were actively recruited
for participation via mailed surveys and accompanying study
information. Although electronic medical record diagnostic
codes were used to define our CDW search parameters and
establish a set of eligible participants, these codes were not
extracted for use in our dataset. This decision was made to
protect patients’ privacy, especially those patients who chose
not to participate. The only information extracted from patient’s
charts was name and mailing address.
We used a modified Dillman method for recruitment [30]. The
400 veterans identified as potential participants were sent a
series of 3 mailings, each including a letter inviting the veteran
to participate, a study fact sheet, the survey, a postage-marked
opt-out postcard, and a postage-marked return envelope. In
addition, the first mailing contained a $10 Patron coupon for
use at the local VA facility cafeteria and general store. The study
invitation letter informed veterans that they may keep this
coupon regardless of their decision to participate in this research.
Participants who returned either the survey or opt-out postcard
were not included in successive mailings.
All recruitment and study procedures were approved by the VA
Boston Healthcare System’s institutional review board.
Survey
Survey items were a combination of validated measures and
newly developed questions based on the literature on technology
use and adoption [31-33]. As there was no precedent for items
evaluating concerns related to mental health app use and/or
interest after clinician endorsement, these items were developed
based on existing literature and field tested among a diverse
team of colleagues with expertise in survey development. Items
on mental health app features of interest to participants were
selected based on a review of the literature on common elements
of depression and anxiety apps [34,35].
The final survey consisted of 38 questions focused on 6 domains:
(1) sociodemographic characteristics; (2) physical and mental
health symptoms assessed using the SF-1 (first item of the
36-item Short Form Health Survey) for overall health [31,36],
the Patient Health Questionnaire-8 (PHQ-8) for depression
symptom severity [32,37], and Generalized Anxiety Disorder-7
(GAD-7) for anxiety symptom severity [33,38,39]; (3)
technology ownership and use; (4) interest in apps for mental
illness; (5) reasons for not using apps for mental illness; and
(6) interest in specific mental illness app features (see
Multimedia Appendix 1 for a list of items in each domain).
Data Analysis
We aggregated descriptive data on the following: demographic
and health characteristics, devices owned, current technology
use, and ratings on interest in mHealth interventions.
We used paired sample t tests to evaluate the degree to which
provider endorsement impacted participants’ level of interest
in use of mHealth interventions for mental illness. Specifically,
t tests compared participants’ general interest ratings with those
provided when asked how interested they would be in using a
mobile app for mental illness if their primary care provider
(PCP) recommended it. A similar comparison was conducted
between general interest ratings and those provided when asked
how interested they would be in using a mobile app for mental
illness if their mental health provider recommended the app.
Finally, we used t tests to compare interest ratings associated
with PCP recommendation with those associated with mental
health provider recommendation.
We also compiled aggregate descriptive data on the following:
reasons endorsed for using or not using mobile apps for mental
health and interest in specific app features and content.
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Results
Participants
A total of 149 surveys were returned (response rate of 37.3%,
149/400). The resulting sample was fairly balanced on
demographic characteristics (see Table 1). For clarity and
because no item or scale had missing data for more than 8.1%
(12/149) of respondents, all results are reported as percentages
of the full sample.
The mean PHQ-8 score was 11.25 (SD 6.62), and the majority
of the sample (65.8%, 98/149) reported symptoms that met the
PHQ-8 cutoff score of 8, indicating clinically significant
depressive symptoms [40]. The mean GAD-7 score was 9.65
(SD 6.02), and more than half of the sample (56.4%, 84/149)
reported symptoms that met the GAD-7 cutoff score of 8 for
clinically significant anxiety symptoms [33,39]. Self-reported
mental health conditions were collected and are detailed in Table
1.
Technology Ownership and Use
The majority of the participants reported owning a smartphone
(75.8%, 113/149) and a smaller portion reported owning a tablet
(45.6%, 68/149). Together, a total of 119 participants (79.9%,
119/149) reported owning a smart device that could be used to
run a mental health app. Table 2 displays participant answers
with regard to current app and smart device technology use.
Interest in Apps for Mental Illness
When asked how interested they would be in using an app for
mental illness, 73.1% (87/149) reported some level of interest.
Specifically, 12.8% (19/149) indicated that they would be
completely interested, 22.1% (33/149) indicated that they would
be very interested, 22.8% (34/149) indicated that they would
be moderately interested, and 15.4% (23/149) indicated that
they would be a little interested. When the sample was limited
to only those who owned a smart device, the percentage of
individuals with some level of interest in using an app for mental
illness was slightly higher (77.3%, 92/149).
In addition, when asked about interest in apps that could deliver
context-sensitive feedback (ie, utilizing passive sensors to
respond to physical or behavioral changes), the majority of the
sample (84.0%, 125/149) reported some interest. Specifically,
28.9% (43/149) reported that they would be completely
interested, 26.2% (39/149) reported that they would be very
interested, 16.1% (24/149) reported that they would be
moderately interested, and 12.8% (19/149) reported that they
would be a little interested. When the sample was limited to
only those who owned a smart device, the percentage of
individuals interested in an app that delivered context-sensitive
feedback was only slightly higher (86.6%, 103/149).
Relationship Between Interest in Apps for Mental
Illness and Provider Endorsement
Paired sample t tests were used to determine whether provider
endorsement would impact interest levels. Starting with an
alpha=.05 as the critical P value, the Bonferroni corrected P
value for 3 t tests was .017. Participants rated global interest
independent of provider endorsement (mean 2.81 [SD 1.38])
significantly lower than interest in the context of PCP
endorsement (mean 3.13 [SD 1.38], t147=−5.65, P<.001, d=0.23).
Similarly, participants rated global interest independent of
provider endorsement (mean 2.81 [SD 1.38]) significantly lower
than interest in the context of mental health provider
endorsement (mean 3.30 [SD 1.36], t145=−4.05, P<.001, d=0.36).
Finally, participants rated interest in the context of PCP
endorsement (mean 3.13 [SD 1.38]) significantly lower than
interest in the context of mental health provider endorsement
(mean 3.30 [SD 1.36], t145=−3.37, P<.001, d=0.12). When the
sample was limited to only those who owned smart devices
(n=119), these comparisons remained significant at the P<.001
level in the same directions.
Reasons for Not Using Apps for Mental Illness
Table 3 displays the frequency with which participants endorsed
specific reasons for not using mental health apps. The most
commonly endorsed reasons were not having proof that the app
would work, concerns about privacy, and not knowing where
to find such an app. These were the most commonly endorsed
reasons both when the full sample was considered and when
the sample was limited to only those participants who owned
smart devices.
Interest in Specific Mental Illness App Features
Table 4 displays the frequency with which participants endorsed
interest in features of mental health apps. The features with the
highest interest ratings related to increasing exercise, getting
better sleep, cognitive restructuring (changing negative or
self-critical thinking), and behavioral activation (getting
involved in more activities). These features were the most
frequently endorsed both when the full sample was considered
and when the sample was limited to only those participants who
owned smart devices.
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Table 1. Demographic characteristics of the sample (N=149).
StatisticsCharacteristics
57.5 (13.9)Age (years), mean (SD)
Gender, n (%)
77 (51.7)Male
67 (45.0)Female
5 (3.4)Not reported
Race or ethnicity, n (%)
67 (45.0)Caucasian or white
44 (29.5)African American or black
11 (7.4)Other
9 (6.0)Hispanic or Latino
7 (4.7)Not reported
6 (4.0)Asian
4 (2.7)American Indian, Alaskan Native
1 (0.7)Pacific Islander
Education, n (%)
1 (0.7)Middle school (7th-8th)
24 (16.1)High school (9th-12th)
41 (27.5)Some college or vocational school
16 (10.7)Associates degree (2-year college)
36 (24.2)Bachelor’s degree (4-year college or university)
27 (18.1)Graduate degree
4 (2.7)Not reported
134 (89.9)English as first language, n (%)
Marital status, n (%)
49 (32.9)Divorced or separated
46 (30.9)Married
39 (26.2)Single, never married
11 (7.4)Widowed
4 (2.7)Not reported
Annual household income, n (%)
36 (24.2)Less than US $20,000
21 (14.1)US $20,000 to US $34,999
35 (23.5)US $35,000 to US $49,999
20 (13.4)US $50,000 to US $74,999
15 (10.1)US $75,000 to US $99,999
8 (5.4)US $100,000 to US $149,999
2 (1.3)US $150,000 or more
12 (8.1)Not reported
Self-reported health rating, n (%)
3 (2.0)Excellent
21 (14.1)Very good
56 (37.6)Good
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StatisticsCharacteristics
51 (34.2)Fair
11 (7.4)Poor
6 (4.0)Not reported
Self-reported behavioral health conditions, n (%)
107 (71.8)Depression
97 (65.1)Stress
96 (64.4)Anxiety
93 (62.4)Difficulty sleeping
91 (61.1)Posttraumatic stress disorder
88 (59.1)Chronic pain
76 (51.0)Overweight
32 (21.5)Smoking
26 (17.4)Diabetes
15 (10.1)Substance use disorder (not alcohol)
14 (9.4)Alcohol use disorder
Table 2. Technology use characteristics of sample (N=149).
Frequency endorsed, n (%)Type of technology use
Smartphone or tablet functions
118 (79.2)Texting
116 (77.9)Taking pictures or camera
106 (71.1)Apps
104 (69.8)Searching the internet
103 (69.1)Checking the weather forecast
101 (67.8)Email
95 (63.8)Driving or walking directions
83 (55.7)Social media
Use of apps for other health-related goals
42 (28.2)Daily steps
34 (22.8)Tracking calories
31 (20.8)Mindfulness exercises
30 (20.1)Weight management
28 (18.8)Sleep
16 (10.7)Mental illness
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Table 3. Factors impacting use of mental health apps.
Full sample
(N=149), n (%)
Smart device owners
(n=119), n (%)
Reason
107 (71.8)92 (77.3)I might use an app for these problems if I saw proof that it worked.
88 (59.1)73 (61.3)I am concerned about protecting my privacy with having my information in an app like this.
76 (51.0)61 (51.3)I don’t know how to find an app that would help.
55 (36.9)44 (37.0)I don’t think an app can help me to get better.
52 (34.9)43 (36.1)I am already in treatment for stress, depression, anxiety or PTSDa and don’t see the need for an app.
39 (26.2)31 (26.1)It would be embarrassing to have an app like this on my phone.
29 (19.5)13 (10.9)I don’t use apps at all.
14 (9.4)13 (10.9)I tried an app like this before and did not like it because it was not personalized enough.
21 (14.1)12 (10.1)I don’t think I have a problem with stress, depression, anxiety or PTSD.
11 (7.4)11 (9.2)I tried an app like this before and it did not help.
12 (8.1)10 (8.4)I tried an app like this before and did not like it because it was difficult to use.
aPTSD: posttraumatic stress disorder.
Table 4. Interest in specific features of mental health apps.
Full sample
(N=149), n (%)
Smart device owners
(n=119), n (%)
Item wording (intervention label)
113 (75.8)95 (79.8)Increase your physical activity or exercise (physical activity)
109 (73.2)87 (73.1)Help you learn to get better sleep (Cognitive Behavioral Therapy for Insomnia)
105 (70.5)86 (72.3)Learn how to change negative/self-critical thinking (cognitive restructuring)
100 (67.1)86 (72.3)Get involved in more activities (behavioral activation)
95 (63.8)80 (67.2)Track mood/stress/anxiety/PTSDa symptoms (progress monitoring)
98 (65.8)79 (66.4)Speak with a health coach when your symptoms are bad. (professional support)
92 (61.7)77 (64.7)Learn more about your mental health condition. (psychoeducation)
92 (61.7)75 (63.0)Help improve your social skills (social skills training)
91 (61.1)73 (61.3)Remind you to take your medications. (medication adherence)
72 (48.3)61 (51.3)Connect with a community of people with similar mental health problems (social support)
aPTSD: posttraumatic stress disorder.
Discussion
Principal Findings
Results from this study indicate that access and interest in mobile
apps for mental illness outpace actual use. Specifically, we
found that access to devices and use of apps, in general, was
high: nearly 80% of our sample reported owning smart devices,
and of those with smart devices, nearly 90% reported that they
use apps. Interest in using mobile apps for mental illness was
also high: over 70% of the sample indicated that they have some
level of interest. Despite owning the requisite devices, having
active and relevant diagnoses (as indicated by PHQ-8 and
GAD-7 scores), and expressing interest, use of mobile apps for
mental illness was low: only 1 in 10 participants used apps for
mental illness. These findings could be interpreted as indicating
that most participants wanted to use mHealth interventions for
mental illness and had the device and technology knowledge to
do so.
Findings also provide some guidance into factors that may
impact adoption. First, the highest-rated reasons for not using
apps for mental health were related to not having proof of
efficacy, concerns about whether these apps could keep mental
health information adequately private, and not knowing where
to find such an app. These findings suggest that public
dissemination of information on efficacy of apps for mental
illness (eg, in doctors’ offices or on public transportation) could
improve adoption. Moreover, informing users how information
within the app is protected (eg, in the introductory screens of
the app) may increase adoption. Concerns related to efficacy
and privacy are supported by earlier studies [21,22,41], but until
recently [23], lack of information on where to find
evidence-based apps has not been clearly articulated as a barrier
to adoption. With regard to barriers to adoption, it is important
to specifically note that this study did not evaluate cost as a
barrier to adoption for 2 reasons. First, within VA, cost concerns
of medical care are different than outside VA. Second, VA has
developed a number of mobile apps for mental illness that are
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freely available to the public and relevant for the veterans
recruited in this study.
Provider endorsement also appears to be a promising avenue
for increasing adoption of mHealth for mental illness.
Participants provided significantly higher interest ratings in the
context of provider endorsement than when asked more
generally about interest in using such apps. These findings are
consistent with existing literature on the impact of provider
endorsement in patient adoption of other patient-facing
technologies (eg, patient portals that offer messaging and other
features) [20]. These findings go beyond the existing literature,
however, by showing that the type of provider endorsing the
intervention may matter because interest ratings were greater
in the context of mental health provider endorsement than PCP
endorsement. Provider recommendation is not currently the
norm; recent research suggests that individuals are more likely
to hear about mental health apps through social media, Web
searches, or friends than through medical providers [23].
Findings from our study underscore that providers could
potentially play a key role in increasing adoption. Findings also
raise questions about who among providers should be endorsing
mHealth interventions to maximize the chances of adoption.
Although this study did not seek to directly test existing models
of technology adoption, some interesting parallels between these
findings and existing models were observed. Specifically, the
Unified Theory of Acceptance and Use of Technology [15]
indicates that 2 key determinants of technology adoption and
use are performance expectancy (a user’s beliefs on whether
the technology will be helpful) and social influence (how
strongly an individual believes that important others think he
or she should use the technology). Findings that both proof of
efficacy and provider endorsement would encourage use are
consistent with these 2 theoretical constructs. Considering the
results from this research in relation to such constructs is
particularly important to understanding how evolving theories
of technology adoption can best be applied in different contexts,
including patient adoption of technology and its integration into
mental health treatment.
Findings also provide insight into what features and content of
apps patients with depression, anxiety, and/or PTSD may find
most useful. Over 70% of participants with smart devices
reported interest in using apps that facilitate core functions of
cognitive behavioral therapy such as cognitive restructuring and
behavioral activation. Over 73% of participants with smart
devices reported interest in features that would promote wellness
in areas of behavioral health such as sleep difficulties and
inactivity. These findings suggest that this population may be
best served by individual apps or suites of apps that target
depression and anxiety from multiple angles [10].
In addition, interest in context-sensing mobile app interventions
was high; 85% of participants indicated some level of interest
in this type of intervention. This finding contrasts with other
research where participants endorsed skepticism and concern
over context sensing [41]. Interest in context-sensing mobile
app interventions may indicate an interest in personalization.
Along these lines, Table 3 shows that the majority of those who
reported having used an app for mental health also endorsed
that they did not like it because it was not sufficiently
personalized. This finding should be interpreted with caution
because we do not know which apps these participants used,
and it is difficult to draw conclusions based on such a small
subsample (only 10.7% of the full sample had used apps for
mental illness). However, other research corroborates that patient
reports of insufficient personalization is a perceived barrier to
using mobile treatment apps for depression [22].
It was also worth noting that although participants endorsed
interest in apps that offered the option of speaking to a health
coach, 5 other features were endorsed more frequently than this
feature. There has been a lot of emphasis on the integration of
health coaching into app platforms both as a way to enhance
engagement and as a way to produce higher levels of change
[42,43]. On the other side of this debate, some research indicates
that integrating health coaching does not necessarily ensure
engagement in technology-based interventions for depression
as users can simply ignore calls from coaches [44]. Findings
from this study contribute to this debate and indicate that health
coaching capabilities may not be essential for user interest and/or
engagement.
Strengths and Limitations
Key strengths of this study include engagement of a racially
diverse, clinical sample and proactive recruitment methods. By
mailing paper surveys to patients identified as eligible, we expect
to have captured data from individuals who may not have
responded to more passive recruitment approaches (eg, flyers
in waiting rooms). However, our proactively mailed survey
methodology also introduces some bias as it is also possible
that those who were less interested in use of technology were
less likely to respond to the survey. Nevertheless, it is our
expectation that the clinical nature of our sample was appropriate
for our research questions and that our recruitment method
introduced less bias than studies recruiting online or via social
media, which essentially make technology proficiency a
condition for entry into the study.
The sample in this study consisted entirely of veterans receiving
services at a single VA hospital in a metropolitan area in the
northeastern United States. Generalizability of findings to
nonveteran samples and samples collected in other geographical
areas should be tested in future studies. In addition, given the
scope and funding level of this study, the presence of diagnoses
required for eligibility was based on patients’ medical records
and not verified by study staff independently through a
structured clinical interview.
Finally, this study evaluated stated preferences and interests. A
close-ended question format was used for this survey; however,
the downside of survey items formatted in this manner is that
they can produce less nuanced data when answer options do not
fully capture patients’ thoughts. Additional research that includes
more nuanced data collection such as a mixed-methods study
with qualitative interviews will be an important next step.
Moreover, moving forward, it will be necessary to evaluate
whether these self-reported findings hold up behaviorally. That
is, future research will need to assess whether implementation
strategies and platforms consistent with observed preferences
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and interests are associated with positive impact on adoption
and engagement.
Conclusions and Future Directions
Mobile apps are a new and promising adjunctive, and possibly
even stand-alone, treatment option for patients with depression
and anxiety disorders. They are technologies that can reach
patients beyond the confines of traditional brick-and-mortar
clinic visits and engage them directly, in the context of their
daily lives. For these reasons, mobile apps are also a unique
treatment option to implement, one that requires a thorough
understanding of patient perspectives and preferences if effective
implementation strategies are to be designed. As reinforced in
this study, smart devices are ubiquitous and patients are
interested in using this technology. Findings from this study
offer several key takeaway points. First, in this sample of
individuals with clinically significant mood and/or anxiety
symptoms, most were interested in using mobile apps as part
of treatment, but few were doing so. Second, participant interest
ratings suggest that provider endorsement may positively
influence adoption of these technologies. Third, integration of
wearables and passive data to direct interventional content,
interventions to improve self-care around sleep and inactivity,
and common cognitive-behavioral therapy interventions such
as cognitive restructuring and behavioral activation were all
perceived as valuable by patients. Finally, messaging around
these technologies should increase awareness of mobile apps
available for this population, relay what is known around
efficacy, and address privacy concerns. One way to disseminate
these messages could be through patients’ providers, but this
would require that providers have easy access to up-to-date
information on which apps are efficacious and safe.
Evaluating the generalizability of these findings in a nonveteran
sample and determining whether preferences observed here
translate to actual behaviors will be critical moving forward. It
will also be important to evaluate whether patient interest and
concerns are different across various demographic subgroups
(eg, gender, race, age, and education) to determine how best to
create systems that meet the needs of all segments of the
population. Adjusting messaging and implementation strategies
in ways that reflect these findings and evaluating patient
adoption and engagement are essential next steps. In addition,
evaluating whether preferences endorsed translate to preferential
use of specific app features in real-world settings could direct
attention of app developers toward the features that patients
most value.
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